Skip to content
OpenCapital
Get started

ALX Oncology Holdings Inc. ALXO Q3 2025 earnings

Reported November 7, 2025 · Before market open

EPS-$0.41Miss by $0.04
EPS estimate-$0.37

Next report

Aug 11, 2026 (In 1 week)
EPS estimate-$0.15

Versus estimates

Diluted EPS

Q1 2026-$0.17Miss by $0.02Q4 2025-$0.42Miss by $0.04
Q3 2025-$0.41Miss by $0.04
Q2 2025-$0.49Miss by $0.03Q1 2025-$0.58Miss by $0.11Q4 2024-$0.55Beat by $0.17

Ask the moment ALX Oncology Holdings Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did ALX Oncology Holdings Inc. report Q3 2025 earnings?
ALX Oncology Holdings Inc. (ALXO) reported Q3 2025 earnings on November 7, 2025 before market open.
What were ALX Oncology Holdings Inc.'s Q3 2025 revenue and EPS?
ALX Oncology Holdings Inc. reported eps of $-0.41 for Q3 2025.
Did ALX Oncology Holdings Inc. beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.37 by $0.04.
How did ALX Oncology Holdings Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 29.3% from $-0.58.
Where can I find ALX Oncology Holdings Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-271112) and the 10-Q periodic report (0001193125-25-272281) directly on SEC EDGAR. The filing index links above go to sec.gov.